Industry Reports
Novartis announces phase II SUSTAIN study of SEG101 significantly reduces frequency of sickle cell pain crises
Results from the Phase II SUSTAIN study show that SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the median annual rate of sickle cell-related...
News
Cerevance launched with new technology, drug portfolio and $36m in cash to tackle brain diseasesÂ
Takeda Pharmaceutical Company Limited and Lightstone Ventures announced the launch of Cerevance, a neuroscience company focused on discovering and developing novel therapeutics for neurological...
Drug Research
IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
IBM Watson Health and Pfizer Inc announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology,...
Packaging & Labelling
Videojet boosts productivity and efficiency with new CO2 Laser Range
As production targets increase, manufacturers need more efficient laser marking solutions to print consistent high-quality codes on their products. However, these...
Industry Reports
Aegerion Pharmaceuticals INC and QLT INC Complete Merger Transaction ; QLT to Change Name to Novelion Therapeutics Inc
Aegerion Pharmaceuticals Inc and QLT Inc announced the completion of their merger transaction, as a result of which Aegerion is now an indirect wholly-owned...
Industry Reports
Catalent Acquires Accucaps To Expand Softgel Development And Manufacturing Capabilities And Capacity
Catalent Inc the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products announced that it has...
News
Sun Pharma launches first branded ophthalmic product, BromSiteâ„¢, in USA
Sun Pharma announced the launch of BromSiteâ„¢ (bromfenac ophthalmic solution) 0.075% in the US market.A nonsteroidal anti-inflammatory drug indicated for the treatment of postoperative...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read